Literature DB >> 25439581

Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility.

M C Nieto1, O Tellería2, R Cisterna2.   

Abstract

In order to know the epidemiology and the changes of antifungal resistance in invasive candidiasis (IC) we carried out this prospective study of Candida strains belonging to patients admitted to 26 Spanish hospitals from June 2011 to June 2012 diagnosed with IC. Clinical information and the identity of the Candida species were collected and antifungal susceptibility was tested using broth microdilution in five agents: amphotericin B, fluconazole, voriconazole, caspofungin and anidulafungin. A total of 705 cases-isolates were documented. Most of the patients suffered from candidemia and several underlying diseases and more than half of them were neutropenic or under immunosuppressive therapy, factors associated with higher mortality. Thirty percent of global mortality was documented. C. albicans was the most frequently isolated species, although an increase of non-C. albicans species was observed. Resistance to fluconazole was of 3.4%, lower than in previous years (6.3%). C. parapsilosis presented a higher MIC90 of echinocandins compared to other species.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Antifungals; Candidemia; Echinocandins; Epidemiology; Invasive candidiasis; Susceptibility

Mesh:

Substances:

Year:  2014        PMID: 25439581     DOI: 10.1016/j.diagmicrobio.2014.05.021

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  12 in total

1.  Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study.

Authors:  Roberto Luzzati; Maria Merelli; Filippo Ansaldi; Chiara Rosin; Annamaria Azzini; Silvia Cavinato; Pierluigi Brugnaro; Claudio Vedovelli; Annamaria Cattelan; Busetti Marina; Giuseppe Gatti; Ercole Concia; Matteo Bassetti
Journal:  Infection       Date:  2016-07-11       Impact factor: 3.553

2.  Epidemiology and reporting of candidaemia in Belgium: a multi-centre study.

Authors:  C Trouvé; S Blot; M-P Hayette; S Jonckheere; S Patteet; H Rodriguez-Villalobos; F Symoens; E Van Wijngaerden; K Lagrou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-17       Impact factor: 3.267

3.  Monitoring the Epidemiology and Antifungal Resistance of Yeasts Causing Fungemia in a Tertiary Care Hospital in Madrid, Spain: Any Relevant Changes in the Last 13 Years?

Authors:  Judith Díaz-García; Aina Mesquida; Carlos Sánchez-Carrillo; Elena Reigadas; Patricia Muñoz; Pilar Escribano; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

4.  Candida albicans cell shaving uncovers new proteins involved in cell wall integrity, yeast to hypha transition, stress response and host-pathogen interaction.

Authors:  Ana Gil-Bona; Claudia Marcela Parra-Giraldo; María Luisa Hernáez; Jose Antonio Reales-Calderon; Norma V Solis; Scott G Filler; Lucia Monteoliva; Concha Gil
Journal:  J Proteomics       Date:  2015-06-15       Impact factor: 4.044

5.  Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014.

Authors:  Francesco Barchiesi; Elena Orsetti; Rosaria Gesuita; Edlira Skrami; Esther Manso
Journal:  Infection       Date:  2015-09-26       Impact factor: 3.553

6.  Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital.

Authors:  Isabela Haddad Peron; Franqueline Reichert-Lima; Ariane Fidelis Busso-Lopes; Cristiane Kibune Nagasako; Luzia Lyra; Maria Luiza Moretti; Angelica Zaninelli Schreiber
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

Review 7.  Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?

Authors:  Vasiliki Soulountsi; Theodoros Schizodimos; Serafeim Chrysovalantis Kotoulas
Journal:  Infection       Date:  2021-06-16       Impact factor: 3.553

Review 8.  Candida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance.

Authors:  Fleischer Cn Kotey; Nicholas Tkd Dayie; Patience B Tetteh-Uarcoo; Eric S Donkor
Journal:  Infect Dis (Auckl)       Date:  2021-06-24

9.  Factors related to outcome of bloodstream infections due to Candida parapsilosis complex.

Authors:  Francesco Barchiesi; Elena Orsetti; Patrizia Osimani; Carlo Catassi; Fabio Santelli; Esther Manso
Journal:  BMC Infect Dis       Date:  2016-08-09       Impact factor: 3.090

Review 10.  Candida glabrata Biofilms: How Far Have We Come?

Authors:  Célia F Rodrigues; Maria Elisa Rodrigues; Sónia Silva; Mariana Henriques
Journal:  J Fungi (Basel)       Date:  2017-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.